Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Gazzerro

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|December 11, 2003
Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblastsClaudia Palermo, Paola Manduca, Elisabetta Gazzerro, et al.
Cell Cycle (Georgetown, Tex.)|May 15, 2007
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx miceGloria Bonuccelli, Federica Sotgia, Franco Capozza, et al.
Endocrinology|November 13, 2004
Skeletal overexpression of gremlin impairs bone formation and causes osteopeniaElisabetta Gazzerro, Renata C Pereira, Vanda Jorgetti, et al.
Bone|August 29, 2006
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal functionElisabetta Gazzerro, Valerie Deregowski, Lisa Stadmeyer, et al.
The Journal of Biological Chemistry|September 6, 2007
Conditional deletion of gremlin causes a transient increase in bone formation and bone massElisabetta Gazzerro, Anna Smerdel-Ramoya, Stefano Zanotti, et al.
International Journal of Molecular Sciences|August 23, 2020
eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle DiseasesChiara Panicucci, Lizzia Raffaghello, Santina Bruzzone, et al.
Der Internist|June 18, 2021
[Diagnostics and treatment of statin-associated muscle symptoms]Ursula Kassner, Stefanie Grunwald, Dominik Spira, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2023
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in SarcoglycanopathiesAndrea Benzi, Serena Baratto, Cecilia Astigiano, et al.
Frontiers in Physiology|February 13, 2023
"suMus," a novel digital system for arm movement metrics and muscle energy expenditureTeresa Gerhalter, Christina Müller, Elke Maron, et al.
International Journal of Molecular Sciences|July 27, 2024
Undetected Neuromuscular Disease in Patients after Heart TransplantationBiniam Melese Bekele, Elisabetta Gazzerro, Felix Schoenrath, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Endocrinology and Metabolism|December 11, 2003
Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblastsClaudia Palermo, Paola Manduca, Elisabetta Gazzerro, et al.
Cell Cycle (Georgetown, Tex.)|May 15, 2007
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx miceGloria Bonuccelli, Federica Sotgia, Franco Capozza, et al.
Endocrinology|November 13, 2004
Skeletal overexpression of gremlin impairs bone formation and causes osteopeniaElisabetta Gazzerro, Renata C Pereira, Vanda Jorgetti, et al.
Bone|August 29, 2006
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal functionElisabetta Gazzerro, Valerie Deregowski, Lisa Stadmeyer, et al.
The Journal of Biological Chemistry|September 6, 2007
Conditional deletion of gremlin causes a transient increase in bone formation and bone massElisabetta Gazzerro, Anna Smerdel-Ramoya, Stefano Zanotti, et al.
International Journal of Molecular Sciences|August 23, 2020
eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle DiseasesChiara Panicucci, Lizzia Raffaghello, Santina Bruzzone, et al.
Der Internist|June 18, 2021
[Diagnostics and treatment of statin-associated muscle symptoms]Ursula Kassner, Stefanie Grunwald, Dominik Spira, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2023
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in SarcoglycanopathiesAndrea Benzi, Serena Baratto, Cecilia Astigiano, et al.
Frontiers in Physiology|February 13, 2023
"suMus," a novel digital system for arm movement metrics and muscle energy expenditureTeresa Gerhalter, Christina Müller, Elke Maron, et al.
International Journal of Molecular Sciences|July 27, 2024
Undetected Neuromuscular Disease in Patients after Heart TransplantationBiniam Melese Bekele, Elisabetta Gazzerro, Felix Schoenrath, et al.
Pageof 5